No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
1955 |
6. Filter based on genotype QC (FinnGen only) |
907 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Acute myeloid leukaemia and myelodysplastic syndromes
based on the number of shared cases.
Similar with more cases:
- Liquid cancers
- Liquid cancers, including Hilmo
- Malignant neoplasm
- Malignant neoplasm, including Hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 907 | 352 | 555 |
| Unadjusted period prevalence (%) | 0.20 | 0.12 | 0.25 |
| Median age at first event (years) | 73.45 | 71.88 | 74.45 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 968
- Matched controls
- 9680
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WW500
NOMESCO Finland
Blood transfusion
68.8
307.7
361
83
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2701.1
307.7
646
7
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
920.7
307.7
314
5
XW000
NOMESCO Finland
Bone marrow biopsy
126.9
307.7
554
101
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
+∞
307.7
299
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
307.7
344
*
A04AA01
ATC
ondansetron; systemic, rectal
43.3
307.7
295
97
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
307.7
475
*
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
1197.8
283.2
263
*
D64.9
ICD-10 Finland
Anaemia, unspecified
9.4
259.4
433
768
B03XA02
ATC
darbepoetin alfa; parenteral
34.8
250.7
163
56
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
26.8
241.8
173
78
Z51.5
ICD-10 Finland
Palliative care
12.8
226.7
250
257
L03AA02
ATC
filgrastim; parenteral
1272.0
215.1
202
*
127
Kela drug reimbursment
Transplant complication
57.5
213.2
121
24
D70.89
ICD-10 Finland
Neutropenic splenomegaly
67.2
205.2
113
19
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
23.8
201.4
150
74
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
84.0
197.5
105
14
A05AA02
ATC
ursodeoxycholic acid; oral
35.7
174.0
111
35
B03XA01
ATC
erythropoietin; parenteral
48.3
149.8
88
20
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.3
144.5
315
693
ZX112
NOMESCO Finland
Subcutaneous
41.5
142.8
87
23
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
774.0
139.5
134
*
JN4AD
NOMESCO Finland
Body CT examination
8.3
136.7
204
302
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
+∞
124.7
117
*
L04AD01
ATC
ciclosporin; systemic
30.2
124.1
83
30
R50.9
ICD-10 Finland
Fever, unspecified
5.4
121.2
315
799
H02AB02
ATC
dexamethasone; systemic
21.9
116.3
88
44
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
1187.4
110.8
106
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
63.9
108.1
60
10
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.3
103.3
258
625
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.7
103.2
158
238
JN4BD
NOMESCO Finland
Extensive body CT
8.2
97.3
140
196
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
91.1
86
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
941.1
89.2
86
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.0
89.0
149
246
J01MA12
ATC
levofloxacin; systemic
4.1
88.7
335
1106
L01XX05
ATC
hydroxycarbamide; oral
319.9
87.2
87
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
86.8
82
*
J05AB11
ATC
valaciclovir; oral
4.6
86.3
257
710
C61
ICD-10 Finland
Malignant neoplasm of prostate
315.7
86.2
86
*
JN6AD
NOMESCO Finland
CT of torso and neck
34.3
81.2
52
16
M04AA01
ATC
allopurinol; systemic
4.0
81.0
311
1031
ZX120
NOMESCO Finland
Intravenous
5.8
80.4
164
328
N02AA05
ATC
oxycodone; systemic
4.0
79.8
306
1012
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
29.5
79.0
53
19
J02AC03
ATC
voriconazole; systemic
414.4
78.0
77
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
22.8
75.9
56
26
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
9.7
74.3
90
101
D46.1
ICD-10 Finland
Refractory anaemia with ring sideroblasts
390.9
73.8
73
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.3
71.6
221
621
A04AA02
ATC
granisetron; systemic, transdermal
355.9
67.4
67
*
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
344.3
65.3
65
*
TGC00
NOMESCO Finland
Bronchial lavation
9.2
63.6
80
94
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
60.8
606
3434
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
625.5
60.4
59
*
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
+∞
60.0
57
*
116
Kela drug reimbursment
Prostate cancer
+∞
60.0
57
*
WW200
NOMESCO Finland
Immunization
9.3
58.9
73
84
306
Kela drug reimbursment
Erythropoietin and darbepoetin
209.2
57.7
59
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.7
57.6
116
227
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
56.8
54
*
L01BB02
ATC
mercaptopurine; oral
20.9
55.0
42
21
L03AA13
ATC
pegfilgrastim; parenteral
292.3
54.8
55
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
54.7
52
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.1
54.4
63
66
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
546.6
53.0
52
*
L04AA06
ATC
mycophenolic acid; systemic
12.4
51.8
52
44
A41.9
ICD-10 Finland
Sepsis, unspecified
5.4
49.2
104
212
D64.8
ICD-10 Finland
Other specified anaemias
9.1
47.8
60
70
399
Kela drug reimbursment
Venetoclax
+∞
46.2
44
*
B73
ICPC
Leukaemia
+∞
45.2
43
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
5.3
44.8
95
194
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
457.9
44.6
44
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
44.1
42
*
1518, ,
Kela drug reimbursment
+∞
44.1
42
*
J01MA14
ATC
moxifloxacin; systemic
3.8
43.8
153
460
WZC00
NOMESCO Finland
Treatment plan or consultation
2.7
43.5
326
1529
L02AE02
ATC
leuprorelin; implant, parenteral
120.6
43.1
46
*
L01XX52
ATC
venetoclax; oral
+∞
43.0
41
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
10.3
42.1
48
49
9982/3-C42.1
ICD-O-3
Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia of bone marrow
+∞
42.0
40
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
+∞
42.0
40
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
70.4
41.4
47
7
115
Kela drug reimbursment
Breast cancer
+∞
40.9
39
*
WF002
NOMESCO Finland
Radical radiotherapy
92.2
40.1
44
5
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
38.0
266
1194
GD1AD
NOMESCO Finland
Thorax CT examination
4.4
37.8
101
249
B82
ICPC
Anaemia other/unspecified
5.5
37.4
75
145
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
8.8
36.7
47
56
J02AC04
ATC
posaconazole; systemic
+∞
36.7
35
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
36.1
419
2366
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
+∞
35.6
34
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
35.0
391
2165
H02AB09
ATC
hydrocortisone; systemic
7.8
34.6
49
66
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.9
34.6
111
313
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
34.6
33
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
34.6
33
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
10.6
34.4
38
37
SPAT1088
SPAT
Blood transfusion
43.8
34.3
42
10
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
33.5
32
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.2
33.0
71
146
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
+∞
32.5
31
*
D45
ICD-10 Finland
Polycythaemia vera
327.4
32.0
32
*
H02AB06
ATC
prednisolone; systemic
2.2
31.6
518
3320
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
31.4
30
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
31.4
30
*
V03AC03
ATC
deferasirox; oral
+∞
31.4
30
*
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
31.4
30
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.5
31.1
79
187
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
113.8
30.8
33
*
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
+∞
30.4
29
*
130
Kela drug reimbursment
Malignant tumour
+∞
30.4
29
*
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
11.4
30.3
32
29
D70.82
ICD-10 Finland
Drug-induced neutropenia
70.3
30.1
34
5
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.5
30.0
112
349
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.6
29.7
73
168
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
29.3
28
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
29.0
152
580
C90.0
ICD-10 Finland
Multiple myeloma
300.6
28.9
29
*
WW409
NOMESCO Finland
Other aferesis
+∞
28.3
27
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
28.3
27
*
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
28.3
27
*
TPH00
NOMESCO Finland
Phlebotomy
66.1
28.1
32
5
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
29.5
27.8
37
13
B02AA02
ATC
tranexamic acid; systemic
3.0
27.4
133
485
WF049
NOMESCO Finland
Radiotherapy of metastasis
267.4
25.8
26
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.8
25.3
40
61
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
25.1
24
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
25.1
24
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
25.1
24
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
25.1
24
*
J02AC01
ATC
fluconazole; systemic
2.1
24.8
327
1883
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
24.7
246
1268
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.2
24.5
103
345
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
24.1
23
*
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
+∞
24.1
23
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
24.1
23
*
L02BB03
ATC
bicalutamide; oral
+∞
24.1
23
*
9980/3-C42.1
ICD-O-3
Myelodysplastic syndrome with single lineage dysplasia of bone marrow
+∞
24.1
23
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
24.1
23
*
Y77
ICPC
Malignant neoplasm prostate
245.8
23.7
24
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.3
23.7
63
154
J05AB01
ATC
aciclovir; systemic
2.3
23.5
229
1167
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
34.3
23.4
30
9
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
+∞
23.0
22
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.6
22.9
56
128
ZX090
NOMESCO Finland
Other technic of radiotherapy
85.5
22.8
25
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
85.5
22.8
25
*
L02BG04
ATC
letrozole; oral
33.2
22.5
29
9
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.9
22.2
50
107
XX3DW
NOMESCO Finland
Time consuming IT work
3.9
22.2
68
185
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
22.0
471
3183
A02BC02
ATC
pantoprazole; systemic
2.0
22.0
654
4937
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
22.0
21
*
9873/3-C42.1
ICD-O-3
Acute myeloid leukemia without maturation of bone marrow
+∞
22.0
21
*
2050A
ICD-9 Finland
Myeloid leukaemia, Acute
+∞
22.0
21
*
HA1AA
NOMESCO Finland
X-ray mammography
4.9
21.7
48
101
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
224.9
21.7
22
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
21.3
142
609
9985/3-C42.1
ICD-O-3
Myelodysplastic syndrome with multilineage dysplasia of bone marrow
+∞
20.9
20
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
20.9
20
*
D46.4
ICD-10 Finland
Refractory anaemia, unspecified
112.5
20.6
22
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
49.1
20.2
24
5
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.0
20.2
36
62
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
20.1
158
730
L04AD02
ATC
tacrolimus; systemic
19.3
20.0
30
16
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.9
20.0
98
358
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
58.8
20.0
23
*
9920/3-C42.1
ICD-O-3
Therapy-related myeloid neoplasm of bone marrow
+∞
19.9
19
*
9895/3-C42.1
ICD-O-3
Acute myeloid leukemia with myelodysplasia-related changes of bone marrow
+∞
19.9
19
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
19.9
19
*
J05AX18
ATC
letermovir; oral
+∞
19.9
19
*
1BC07, ,
NOMESCO Finland
+∞
19.9
19
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.7
19.8
46
101
212
Kela drug reimbursment
Gout
4.4
19.7
50
118
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
47.0
19.3
23
5
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.2
19.1
78
256
175
Kela drug reimbursment
Deferasirox
+∞
18.8
18
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
18.8
18
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.8
18.4
42
91
NK6AN
NOMESCO Finland
Total body bone isotope imaging
44.9
18.3
22
5
A40.8
ICD-10 Finland
Other streptococcal sepsis
6.6
18.0
29
45
J01MA02
ATC
ciprofloxacin; systemic
1.8
18.0
409
2767
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
17.8
362
2364
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
67.9
17.8
20
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
17.8
309
1920
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.5
17.6
117
499
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
51.0
17.0
20
*
ZX121
NOMESCO Finland
Central venous catheter
64.5
16.8
19
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
16.7
288
1777
J02AC05
ATC
isavuconazole; systemic
+∞
16.7
16
*
9874/3-C42.1
ICD-O-3
Acute myeloid leukemia with maturation of bone marrow
+∞
16.7
16
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
16.7
16
*
B01AB05
ATC
enoxaparin; parenteral
1.9
16.7
295
1836
B74
ICPC
Malignant neoplasm blood other
172.9
16.5
17
*
L02BA01
ATC
tamoxifen; oral
172.9
16.5
17
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
172.9
16.5
17
*
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
40.8
16.4
20
5
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
30.6
16.2
21
7
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
48.4
16.1
19
*
R04.0
ICD-10 Finland
Epistaxis
2.5
16.0
110
476
D75.2
ICD-10 Finland
Essential thrombocytosis
34.0
15.8
20
6
1DB06, ,
NOMESCO Finland
+∞
15.7
15
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
15.7
15
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
15.7
15
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
15.7
15
*
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
+∞
15.7
15
*
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
+∞
15.7
15
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
26.8
15.6
21
8
JN4CD
NOMESCO Finland
Very extensive body CT
5.7
15.6
29
52
D46.3
ICD-10 Finland
Refractory anemia with excess of blasts with transformation
86.5
15.6
17
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
162.5
15.5
16
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
162.5
15.5
16
*
L04AA01
ATC
[U] ciclosporin
11.1
15.0
28
26
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
57.6
14.8
17
*
A79
ICPC
Malignancy NOS
57.6
14.8
17
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.6
14
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
14.6
14
*
L03AB05
ATC
interferon alfa-2b; parenteral
+∞
14.6
14
*
D46
ICD-10 Finland
Myelodysplastic syndromes
+∞
14.6
14
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
14.6
14
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
14.6
14
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
14.6
14
*
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
+∞
14.6
14
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
152.2
14.5
15
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
22.7
14.3
20
9
A41.8
ICD-10 Finland
Other specified sepsis
4.2
14.1
38
94
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
11.6
13.8
25
22
UJF32
NOMESCO Finland
Coloscopy
1.8
13.8
247
1531
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
13.6
13
*
9867/3-C42.1
ICD-O-3
Acute myelomonocytic leukemia, NOS, of bone marrow
+∞
13.6
13
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
13.6
13
*
B99
ICPC
Blood/lymph/spleen disease other
34.6
13.5
17
5
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
13.5
220
1323
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
13.3
93
406
H02AB04
ATC
methylprednisolone; systemic
2.0
13.2
154
827
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.4
13.0
48
148
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.3
13.0
33
78
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.7
12.9
24
43
C03CA01
ATC
furosemide; systemic
1.7
12.7
426
3122
122
Kela drug reimbursment
Aplastic anaemia
70.8
12.6
14
*
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
32.5
12.6
16
5
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
12.5
12
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
12.5
12
*
9866/3-C42.1
ICD-O-3
Acute promyelocytic leukemia, t(15;17)(q22;q11-12) of bone marrow
+∞
12.5
12
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
12.5
12
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.4
12.3
45
138
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
6.1
12.2
21
35
B01AB10
ATC
tinzaparin; parenteral
2.4
12.1
86
377
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
47.3
11.9
14
*
SPAT1074
SPAT
Venesection
30.4
11.7
15
5
WW500, ,
SPAT
65.8
11.6
13
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
23.2
11.6
16
7
L01BC06
ATC
capecitabine; oral
+∞
11.5
11
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
11.5
11
*
2AX04, ,
NOMESCO Finland
+∞
11.5
11
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
11.5
11
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
11.5
11
*
C92.3
ICD-10 Finland
Myeloid sarcoma
+∞
11.5
11
*
WW200, ,
SPAT
0.5
11.4
109
1999
J01FF01
ATC
clindamycin; systemic
1.7
11.3
243
1576
D53.1
ICD-10 Finland
Other megaloblastic anaemias, not elsewhere classified
17.3
11.2
17
10
L57.0
ICD-10 Finland
Actinic keratosis
2.2
11.2
98
471
HAB40
NOMESCO Finland
Wedge excision of mammary gland
20.3
11.2
16
8
KCD02
NOMESCO Finland
Transurethral resection of bladder
11.3
11.1
20
18
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
12.1
10.9
19
16
A07AA02
ATC
nystatin; oral
2.5
10.8
67
276
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
9.0
10.8
22
25
H02AB07
ATC
prednisone; oral
1.9
10.7
143
801
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
28.4
10.7
14
5
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
21.7
10.7
15
7
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.4
10.6
75
328
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
10.5
249
1654
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.9
10.5
50
180
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
111.2
10.4
11
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
10.4
10
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
10.4
10
*
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
10.4
10
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
10.4
10
*
174
Kela drug reimbursment
Ruxolitinib
+∞
10.4
10
*
1DB07, ,
NOMESCO Finland
+∞
10.4
10
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
10.4
10
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
10.4
10
*
ZXD05
NOMESCO Finland
Urgent procedure
1.6
10.4
279
1913
Z3231
NOMESCO Finland
Registered nurse
1.7
10.4
236
1550
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.6
10.3
24
53
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.8
10.3
53
199
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.4
10.2
37
113
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
10.1
297
2079
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
9.3
10.0
20
22
R4110
NOMESCO Finland
Physiotherapy
1.7
9.8
238
1586
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
26.3
9.8
13
5
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.0
9.7
42
143
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.3
9.6
77
357
D11AH01
ATC
tacrolimus; topical
10.2
9.5
18
18
D07AB08
ATC
desonide; topical
2.0
9.5
103
536
PJA10
NOMESCO Finland
Exploration of lymph nodes
15.2
9.5
15
10
WZC30
NOMESCO Finland
Teaching
2.0
9.4
112
603
D69.5
ICD-10 Finland
Secondary thrombocytopenia
30.3
9.4
12
*
L01XX35
ATC
anagrelide; oral
+∞
9.4
9
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
9.4
9
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
9.4
9
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
9.4
9
*
374
Kela drug reimbursment
Ruxolitinib
+∞
9.4
9
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
9.4
9
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
9.4
9
*
A04AD12
ATC
aprepitant; systemic
+∞
9.4
9
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
9.4
9
*
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
+∞
9.4
9
*
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
8.8
9.3
19
22
N05AX08
ATC
risperidone; systemic
0.3
9.3
20
721
J01DB01
ATC
cefalexin; oral
1.6
9.1
705
6079
L03.9
ICD-10 Finland
Cellulitis, unspecified
3.8
9.1
27
72
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.4
9.1
65
287
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.7
9.0
28
77
TAB00
NOMESCO Finland
Lumbar puncture
2.8
8.9
45
167
B02BX05
ATC
eltrombopag; oral
24.3
8.9
12
5
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.2
8.8
34
108
XG410
NOMESCO Finland
Flow-volume spirometry
2.7
8.8
48
186
D64.1
ICD-10 Finland
Secondary sideroblastic anaemia due to disease
50.5
8.7
10
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
8.3
8.6
18
22
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
27.8
8.5
11
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
27.8
8.5
11
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
90.8
8.4
9
*
D61.0
ICD-10 Finland
Constitutional aplastic anaemia
90.8
8.4
9
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
90.8
8.4
9
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
8.3
8
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
8.3
8
*
T86.9
ICD-10 Finland
Failure and rejection of unspecified transplanted organ and tissue
+∞
8.3
8
*
L02BB04
ATC
enzalutamide; oral
+∞
8.3
8
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
8.3
8
*
E89.4
ICD-10 Finland
Postprocedural ovarian failure
+∞
8.3
8
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
8.3
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.3
8
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
8.3
8
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
8.3
8
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
8.3
8
*
9872/3-C42.1
ICD-O-3
Acute myeloid leukemia, minimal differentiation of bone marrow
+∞
8.3
8
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
8.3
8
*
ZXE00
NOMESCO Finland
One hour or less
1.5
8.3
313
2302
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
10.9
8.3
15
14
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.5
8.3
28
82
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
14.6
8.2
13
9
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.8
8.2
40
146
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
8.2
204
1363
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
8.1
543
4485
TPX15
NOMESCO Finland
Removal of vascular injection port
33.6
8.1
10
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
17.3
8.1
12
7
ZX108
NOMESCO Finland
Inhalation
10.1
8.0
15
15
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
22.2
8.0
11
5
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
8.0
64
296
N02AX02
ATC
tramadol; systemic, rectal
1.5
8.0
374
2876
P01AB01
ATC
metronidazole; oral, rectal
1.5
7.8
313
2326
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.3
7.7
56
249
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
7.5
7.7
17
23
ZXC96
NOMESCO Finland
Robot assisted procedure
12.0
7.6
13
11
WX892
NOMESCO Finland
Monitored bed care
2.0
7.6
79
406
A07AA09
ATC
vancomycin; oral
4.3
7.5
19
45
ZX100
NOMESCO Finland
Oral
4.3
7.5
19
45
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
4.5
7.4
18
41
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
80.7
7.4
8
*
L02BG06
ATC
exemestane; oral
80.7
7.4
8
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.3
7.4
27
83
ZX114
NOMESCO Finland
Intramuscular
6.0
7.4
19
32
N05CF01
ATC
zopiclone; oral
1.5
7.4
309
2314
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.5
7.3
87
1512
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
7.3
7
*
C92.2
ICD-10 Finland
Atypical chronic myeloid leukaemia, BCR/ABL- negative
+∞
7.3
7
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
7.3
7
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
7.3
7
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
+∞
7.3
7
*
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
+∞
7.3
7
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.3
7
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
7.3
7
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
7.3
7
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
7.3
7
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
7.3
7
*
20500
ICD-8 Finland
Myeloid leukaemia, Acute
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
L02BG03
ATC
anastrozole; oral
+∞
7.3
7
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
7.3
7
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
7.3
7
*
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
15.9
7.2
11
7
ED1AA
NOMESCO Finland
Mandibular X-ray examination
15.9
7.2
11
7
K61.0
ICD-10 Finland
Anal abscess
4.5
7.2
17
38
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.6
7.2
23
65
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
30.2
7.2
9
*
Z31.5
ICD-10 Finland
Genetic counselling
3.5
7.2
24
70
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.5
7.1
45
188
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
6.1
7.1
18
30
E83.1
ICD-10 Finland
Disorders of iron metabolism
12.1
7.1
12
10
WVA20
NOMESCO Finland
Medicine administration
3.1
7.1
29
96
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
8.9
7.1
14
16
N02AA01
ATC
morphine; systemic, rectal
3.7
7.1
22
61
A02BC01
ATC
omeprazole; systemic
1.5
7.0
258
1876
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
7.0
180
1208
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.4
7.0
17
39
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
13.9
6.9
11
8
A46
ICD-10 Finland
Erysipelas
1.6
6.9
159
1040
R06AE07
ATC
cetirizine; oral
1.5
6.8
312
2371
EBA10
NOMESCO Finland
Operative extraction of tooth
2.0
6.8
77
408
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
40.3
6.8
8
*
XW000, ,
SPAT
40.3
6.8
8
*
WPB10
NOMESCO Finland
Making a convalescent care decision
16.8
6.8
10
6
K12.10
ICD-10 Finland
Stomatitis NOS
16.8
6.8
10
6
R4190
NOMESCO Finland
Nutritional therapy
3.3
6.7
24
73
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
6.5
6.7
16
25
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.2
6.6
53
246
WPA13
NOMESCO Finland
Palliative consultation
12.3
6.6
11
9
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.3
6.6
24
74
A03
ICPC
Fever
1.7
6.6
116
706
XQ848
NOMESCO Finland
Dermatological photography
3.1
6.5
27
90
C10AA07
ATC
rosuvastatin; oral
0.6
6.5
153
2233
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.6
6.5
21
60
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
70.3
6.4
7
*
JG1BG
NOMESCO Finland
MRI of rectum
70.3
6.4
7
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
70.3
6.4
7
*
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
70.3
6.4
7
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
70.3
6.4
7
*
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
3.9
6.3
18
47
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.9
6.3
18
47
A07EA06
ATC
budesonide; oral, local oral
2.7
6.3
33
126
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
18.1
6.3
9
5
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
9986/3-C42.1
ICD-O-3
Myelodysplastic syndrome with isolated del (5q) of bone marrow
+∞
6.3
6
*
L01EX13
ATC
gilteritinib; oral
+∞
6.3
6
*
C92
ICD-10 Finland
Myeloid leukaemia
+∞
6.3
6
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
6.3
6
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
6.3
6
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
6.3
6
*
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
+∞
6.3
6
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
6.3
6
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
6.3
6
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
6.3
6
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
6.3
6
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
6.3
6
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
6.3
6
*
L03AA10
ATC
lenograstim; parenteral
+∞
6.3
6
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
6.3
6
*
L01XE18
ATC
[U] ruxolitinib
+∞
6.3
6
*
L03AB04
ATC
interferon alfa-2a; parenteral
+∞
6.3
6
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
6.3
6
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
6.3
6
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
6.3
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.3
6
*
G03HA01
ATC
cyproterone; systemic
26.9
6.2
8
*
S77
ICPC
Malignant neoplasm of skin
26.9
6.2
8
*
SPAT1255
SPAT
Intravenous administration of medicine
2.0
6.2
66
342
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
4.0
6.2
17
43
K60.3
ICD-10 Finland
Anal fistula
3.8
6.1
18
48
5BA08, ,
NOMESCO Finland
10.1
6.0
11
11
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
218
89
31.32
318.45
1.6
1.4
146.05
157.34
au/ml
0.36
56
31
358
401
13.58
311.92
2.1
1.6
1.26
1.52
g/l
4.24
313
350
218
76
36.73
307.65
4.4
3.6
586.39
474.80
u/ml
—
18
10
607
1050
13.82
307.65
8.0
2.0
1.92
1.77
%
1.63
577
921
270
137
26.94
307.65
1.4
1.1
148.92
21.40
u/l
11.12
243
120
549
800
14.54
307.65
7.6
2.0
64.99
67.67
e9/l
0.33
442
615
415
68
106.08
307.65
4.7
1.2
—
—
—
0
0
314
188
24.24
307.65
2.6
1.5
—
—
—
0
0
250
96
34.76
307.65
12.1
6.3
562.71
615.79
iu/ml
0.06
41
14
619
790
19.96
307.65
18.5
2.0
303.00
235.32
u/l
6.29
600
738
265
165
21.74
307.65
3.5
2.4
3.67
3.57
g/l
0.30
260
154
204
83
30.87
297.79
11.8
2.3
1.24
1.16
%
0.06
185
67
198
105
23.45
259.45
1.4
1.3
254.71
227.04
u/ml
0.35
113
51
230
179
16.54
248.72
4.2
1.4
—
—
—
0
0
333
457
10.58
245.75
3.1
2.1
10.49
11.16
g/l
1.46
319
422
214
181
14.90
219.47
3.8
1.4
—
—
—
0
0
153
65
27.77
218.21
11.1
2.4
43.56
55.82
%
4.06
134
52
280
368
10.30
211.68
1.8
1.3
1.21
1.13
g/l
0.41
266
339
177
120
17.83
204.98
4.3
1.4
—
—
—
0
0
369
704
7.85
201.50
2.4
1.6
66.24
66.57
g/l
0.32
353
636
127
67
21.67
165.03
5.1
1.3
—
—
—
0
0
128
74
19.78
159.45
5.0
1.3
—
—
—
0
0
103
35
32.81
157.62
1.4
1.4
—
—
—
0
0
103
35
32.81
157.62
1.4
1.4
—
—
—
0
0
87
15
63.63
156.64
1.3
1.0
—
—
—
0
0
407
1090
5.72
150.85
12.2
4.8
1.10
1.03
mmol/l
5.09
392
990
556
2001
5.18
142.63
8.8
2.6
326.19
363.86
umol/l
9.25
533
1685
152
154
11.52
136.73
2.1
1.3
—
—
—
0
0
130
108
13.75
132.87
9.0
6.2
10.33
12.69
mg/l
5.20
123
101
103
55
20.84
132.61
1.7
1.1
—
—
—
0
0
92
46
22.00
121.72
1.7
1.4
—
—
—
0
0
395
1209
4.83
120.74
10.2
2.5
0.80
0.82
mmol/l
2.51
379
1110
131
130
11.50
119.12
1.9
1.3
—
—
—
0
0
405
1280
4.72
118.47
4.1
1.9
29.23
29.92
s
1.26
393
1248
91
50
19.98
115.42
1.2
1.0
—
—
—
0
0
258
575
5.75
114.52
3.4
1.5
—
—
—
0
0
67
16
44.91
112.34
8.8
2.2
1.34
1.84
%
0.21
67
16
690
3370
4.65
108.83
28.3
5.4
32.36
25.89
%
22.33
672
3166
439
1559
4.32
108.25
4.7
1.9
—
—
—
0
0
176
284
7.35
108.13
1.9
1.4
52.15
45.30
mg/l
0.41
155
241
98
72
15.03
107.17
4.0
2.2
—
—
—
0
0
103
84
13.60
105.99
2.3
1.4
—
—
—
0
0
166
257
7.59
105.85
1.9
1.4
3.83
1.36
ratio
0.74
102
155
66
19
37.21
105.44
6.5
1.1
—
—
—
0
0
66
19
37.21
105.44
6.5
1.1
—
—
—
0
0
66
19
37.21
105.44
6.5
1.1
—
—
—
0
0
93
64
15.97
105.38
5.2
1.2
—
—
—
0
0
93
64
15.97
105.38
5.2
1.2
—
—
—
0
0
93
64
15.97
105.38
5.2
1.2
—
—
—
0
0
173
284
7.20
104.46
2.0
1.4
46.19
34.04
mg/l
0.35
151
242
97
0
+∞
102.99
1.0
0.0
—
—
—
0
0
71
31
24.64
98.93
6.2
1.1
—
—
—
0
0
71
31
24.64
98.93
6.2
1.1
—
—
—
0
0
71
31
24.64
98.93
6.2
1.1
—
—
—
0
0
71
31
24.64
98.93
6.2
1.1
—
—
—
0
0
101
92
12.14
96.83
2.2
1.4
—
—
—
0
0
63
23
29.23
93.51
6.8
1.5
613.65
486.59
e6/l
0.47
57
17
159
271
6.82
92.20
3.2
3.1
—
—
—
0
0
391
1414
3.96
91.26
2.6
2.5
18.67
12.28
umol/l
27.18
381
1298
92
5
203.01
89.95
2.3
1.2
—
—
—
0
0
115
139
9.25
89.95
2.2
1.3
—
—
—
0
0
105
114
10.21
89.06
2.2
1.3
—
—
—
0
0
121
159
8.55
88.46
1.5
2.1
24.81
12.49
mg/l
1.51
98
148
352
1208
4.01
88.16
2.6
2.5
38.62
22.26
%
29.80
342
1117
368
1316
3.90
86.60
2.6
2.5
1.97
2.25
g/l
20.55
359
1209
343
1190
3.92
84.01
3.4
1.9
—
—
—
0
0
419
1706
3.57
79.80
18.4
2.1
—
—
—
0
0
171
359
5.57
79.44
1.9
1.4
3.69
3.77
g/l
0.26
160
318
171
359
5.57
79.44
1.9
1.4
6.51
7.62
g/l
12.21
160
318
171
359
5.57
79.44
1.9
1.4
3.92
4.24
g/l
4.42
160
318
169
353
5.59
78.93
2.6
1.6
6.44
2.09
ug/l
0.80
156
304
694
3885
3.78
78.75
49.2
6.0
3.39
4.49
e9/l
3.21
644
3318
678
3748
3.70
78.28
26.1
3.9
13.12
12.68
umol/l
0.44
665
3525
162
331
5.68
77.45
1.9
1.4
3.00
3.02
g/l
0.06
151
290
610
3191
3.46
76.27
19.1
2.5
—
—
estimate
—
0
0
345
1276
3.65
75.67
1.6
1.3
2.61
2.74
g/l
0.54
288
733
672
3748
3.59
75.28
27.7
5.3
0.11
0.20
e9/l
39.74
596
3207
145
275
6.03
74.98
2.2
1.3
—
—
—
0
0
384
1534
3.49
74.44
3.0
1.6
3.26
1.36
mg/l
4.25
344
1205
49
19
27.11
70.99
1.1
1.2
—
—
—
0
0
306
1109
3.57
68.33
3.4
1.9
—
—
—
0
0
146
304
5.48
68.03
1.9
1.4
0.92
0.41
g/l
0.77
130
263
53
29
19.28
66.86
1.3
1.1
—
—
—
0
0
241
760
3.89
66.09
8.9
5.6
9.11
11.32
mmol/l
4.00
232
712
52
28
19.57
66.07
2.2
2.0
36.38
47.35
%
1.78
26
15
474
2271
3.13
66.02
2.9
2.3
2.92
2.82
mg/l
0.36
414
1928
146
319
5.21
64.29
1.7
1.4
11.30
10.64
g/l
0.73
133
277
45
20
23.55
61.89
2.2
3.2
—
—
—
0
0
237
784
3.68
60.08
13.5
2.3
8.94
8.60
umol/l
0.09
225
678
605
3441
3.02
59.99
14.1
3.9
32.89
35.04
g/l
13.85
578
3178
622
3635
2.99
57.86
15.3
5.6
1.19
1.21
mmol/l
4.16
587
3281
123
256
5.36
57.03
2.0
1.4
0.01
0.00
g/l
0.11
117
237
45
25
18.83
56.25
2.8
1.3
—
—
—
0
0
45
25
18.83
56.25
2.8
1.3
—
—
—
0
0
581
3320
2.88
55.53
5.3
3.0
612.40
133.67
ug/l
16.46
548
3052
660
4079
2.94
53.54
18.4
5.9
1.20
1.21
mmol/l
3.14
576
3486
115
245
5.19
51.79
1.8
1.4
0.00
0.00
g/l
-0.00
106
224
49
42
12.24
48.39
2.7
1.3
—
—
—
0
0
49
42
12.24
48.39
2.7
1.3
—
—
—
0
0
55
9
64.66
47.80
1.9
1.2
—
—
—
0
0
45
35
13.44
47.12
1.4
7.0
—
36.36
—
0
11
46
38
12.66
46.46
4.2
1.4
—
—
—
0
0
169
574
3.36
39.97
3.2
1.7
—
—
—
0
0
88
187
5.08
39.54
3.6
1.2
—
—
—
0
0
347
1773
2.49
37.81
2.1
1.8
1271.24
1159.82
nmol/l
1.21
280
1335
76
148
5.49
37.64
1.9
1.4
—
—
—
0
0
120
345
3.83
36.44
6.4
1.7
—
—
—
0
0
79
164
5.16
36.41
1.2
1.3
—
—
—
0
0
340
1763
2.43
35.45
11.5
3.8
78.25
82.45
%
2.47
333
1724
54
83
6.83
33.92
5.0
1.2
—
—
—
0
0
54
83
6.83
33.92
5.1
1.2
—
—
—
0
0
54
83
6.83
33.92
5.1
1.2
—
—
—
0
0
51
76
7.03
32.96
5.3
1.2
—
—
—
0
0
51
77
6.94
32.56
5.3
1.2
—
—
—
0
0
51
77
6.94
32.56
5.3
1.2
—
—
—
0
0
40
11
37.86
31.73
1.6
1.1
—
—
—
0
0
108
320
3.67
31.26
3.3
1.6
—
—
—
0
0
434
2663
2.14
28.78
2.5
1.8
18.87
19.85
nmol/l
0.73
409
2234
159
632
2.81
28.05
1.9
2.0
0.19
0.19
g/l
0.37
141
575
41
59
7.21
27.31
2.3
1.3
—
—
—
0
0
641
4670
2.10
25.67
12.1
4.7
6.90
6.90
mmol/l
0.03
628
4445
34
12
29.30
25.51
1.1
1.2
—
—
—
0
0
566
3959
2.03
25.11
15.2
20.1
1.30
1.39
inr
4.14
508
3368
34
44
7.97
24.79
2.2
1.2
—
—
—
0
0
561
3925
2.02
24.71
3.0
2.3
91.28
93.80
pmol/l
0.66
422
2041
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
88
275
3.42
23.37
3.0
2.7
0.31
0.37
iu/ml
0.86
40
157
30
36
8.57
23.23
2.4
1.3
—
—
—
0
0
31
39
8.18
23.12
2.3
1.3
—
—
—
0
0
366
2247
2.01
22.92
5.7
2.6
33.37
35.03
u/l
0.20
347
2116
111
404
2.97
22.84
3.1
1.5
3.17
2.89
ug/l
0.25
83
304
67
177
3.99
22.75
1.4
1.6
—
—
—
0
0
48
99
5.05
22.22
1.1
1.3
67.08
255.02
miu/ml
—
8
32
379
2388
1.96
21.77
3.3
2.3
48.54
60.83
u/l
5.08
346
2190
120
470
2.77
21.54
1.6
1.6
—
—
—
0
0
139
593
2.57
21.04
6.2
3.8
5.07
5.18
kpa
0.67
129
565
39
77
5.24
18.96
1.1
1.0
—
—
—
0
0
67
203
3.47
18.63
1.4
1.6
0.10
0.15
iu/ml
—
10
44
120
505
2.57
18.60
5.9
3.8
1.55
1.95
mmol/l
0.50
95
360
703
5614
1.92
17.86
33.7
5.6
82.92
78.73
u/l
2.06
689
5201
23
9
26.12
16.96
6.6
1.6
1.74
2.89
%
—
23
9
84
313
2.84
16.48
7.1
4.1
25.25
24.76
mmol/l
0.82
76
284
642
5042
1.81
16.47
7.4
5.0
175.93
2297.20
e6/l
1.70
14
87
383
2620
1.76
15.63
5.0
3.4
174.05
97.84
e6/l
0.38
303
2030
379
2585
1.77
15.63
4.6
2.1
2.31
2.35
mmol/l
5.66
337
2237
428
3023
1.75
15.60
3.8
3.3
2025.73
1806.82
ng/l
0.47
402
2645
220
1270
1.95
15.50
4.7
3.2
2.21
2.15
e6/l
0.03
108
635
64
213
3.15
15.31
1.8
1.5
—
—
—
0
0
24
17
14.44
14.58
1.1
1.0
830.00
920.00
titre
—
10
5
332
2230
1.74
14.12
5.0
3.3
0.57
0.45
e6/l
0.32
254
1665
73
278
2.76
13.74
1.6
2.0
34.56
39.53
u/l
1.18
63
231
405
2896
1.69
13.56
6.1
4.0
103.07
125.43
e6/l
0.17
313
2090
271
1747
1.77
13.15
4.6
4.6
66.55
441.23
ng/l
6.24
233
1504
29
63
4.71
12.65
2.8
1.9
2.54
6086.96
u/l
—
7
16
60
216
2.90
12.54
1.5
1.7
1.11
1.15
g/l
0.37
60
209
427
3142
1.64
12.50
45.4
10.3
0.19
0.00
e9/l
0.92
355
2553
59
212
2.90
12.37
1.5
1.7
0.24
0.22
g/l
0.87
59
207
221
1390
1.76
11.49
4.7
3.1
1.54
1.30
e6/l
0.22
113
764
192
2952
0.56
11.27
2.6
1.9
1.51
1.30
mmol/l
3.07
172
2444
36
103
3.59
10.95
1.2
1.3
—
—
—
0
0
178
1067
1.82
10.82
7.1
6.4
11.24
11.18
kpa
0.06
173
1023
464
3568
1.58
10.79
4.0
2.5
—
—
—
0
0
28
69
4.15
10.47
1.2
1.2
—
—
—
0
0
56
218
2.67
10.13
1.2
1.2
—
33.65
—
0
11
173
1063
1.76
9.61
7.6
6.3
1.07
1.10
mmol/l
0.03
142
861
652
5503
1.57
9.46
6.9
4.3
25.23
13.29
mm/h
27.51
613
5088
20
25
8.14
9.37
1.2
1.2
—
—
—
0
0
19
38
5.08
9.12
1.2
1.2
—
—
—
0
0
27
72
3.83
9.10
1.2
1.1
1.58
1.54
u/ml
0.04
12
24
14
9
15.75
9.05
1.4
1.0
—
—
—
0
0
32
97
3.38
8.95
3.4
3.4
—
—
—
0
0
52
209
2.57
8.85
1.2
1.3
3.50
6.21
u/ml
—
6
34
52
209
2.57
8.85
1.2
1.2
1.00
2.75
u/ml
—
5
23
115
640
1.90
8.77
2.3
2.2
60.42
33.66
u/l
0.49
99
516
68
311
2.28
8.74
1.6
1.9
9.62
7.50
iu/ml
0.33
19
74
8
0
+∞
8.34
11.0
0.0
—
—
—
0
0
32
103
3.18
8.16
1.4
1.4
1526.71
1518.37
e6/l
0.01
24
70
52
219
2.45
8.05
1.4
1.3
—
—
—
0
0
260
1853
1.55
7.92
3.7
2.6
5.28
5.03
e6/l
0.14
246
1689
44
177
2.56
7.51
2.2
1.3
132.23
839.29
e6/l
0.63
35
152
7
0
+∞
7.30
1.1
0.0
—
—
—
0
0
25
74
3.44
7.28
1.2
1.1
4.00
9.09
u/ml
0.46
15
35
151
964
1.67
7.20
5.1
3.4
1.52
2.01
mmol/l
0.72
130
824
46
197
2.40
6.90
1.6
1.4
—
—
—
0
0
46
197
2.40
6.90
1.6
1.4
—
—
—
0
0
42
175
2.46
6.69
2.2
1.3
10.42
56.26
e6/l
0.78
33
147
27
89
3.09
6.66
1.5
1.5
130375.33
110471.87
e6/l
0.07
15
47
17
30
5.75
6.47
1.2
1.4
—
—
—
0
0
518
4351
1.41
6.39
4.3
3.2
68.17
50.47
u/l
2.92
481
3978
17
42
4.10
6.37
1.1
1.9
15.77
14.73
umol/l
0.16
17
36
18
35
5.22
6.34
1.5
1.2
—
—
—
0
0
11
10
11.11
6.30
2.5
1.0
—
—
—
0
0
6
0
+∞
6.25
3.5
0.0
7.83
—
ng/l
—
6
0
46
207
2.28
6.20
4.8
3.6
4.07
1.86
index
0.66
30
103
258
1925
1.46
6.09
1.8
1.8
58491068.71
13813284.49
pmol/l
0.35
212
1571
11
11
10.10
6.04
1.0
1.2
—
—
—
0
0
132
853
1.63
5.98
3.5
3.4
257.81
276.88
ng/l
0.22
120
792
18
49
3.72
5.94
1.1
1.1
—
—
—
0
0
637
7079
0.71
5.86
5.3
6.4
2.26
2.51
mmol/l
10.16
573
6476
46
216
2.19
5.62
1.7
1.6
14033.62
13523.01
e6/l
0.04
37
147
98
597
1.71
5.55
6.9
2.8
1.21
1.22
mmol/l
1.74
92
500
617
6861
0.72
5.36
6.4
7.4
39.24
40.65
mmol/mol
3.79
566
6341
18
53
3.44
5.32
1.1
1.1
—
—
—
0
0
411
3394
1.37
5.26
5.0
4.4
31.61
89.93
ng/l
2.15
341
2667
5
0
+∞
5.21
4.0
0.0
—
—
—
0
0
5
0
+∞
5.21
1.2
0.0
—
—
—
0
0
5
0
+∞
5.21
7.8
0.0
—
—
—
0
0
15
31
4.90
5.13
1.7
1.1
38.94
38.47
g/l
0.09
15
31
8
6
13.43
5.08
1.1
1.3
—
—
—
0
0
19
60
3.21
5.06
1.1
1.1
—
—
—
0
0
18
55
3.32
5.04
1.1
1.1
—
—
—
0
0
18
55
3.32
5.04
1.1
1.1
—
—
—
0
0
13
24
5.48
4.92
1.2
1.1
—
—
—
0
0
28
113
2.52
4.83
2.7
1.3
17.30
8.18
u/l
1.03
20
97
24
90
2.71
4.77
1.3
1.9
29.08
51.62
u/ml
0.50
18
80
12
22
5.51
4.61
1.2
1.2
1.42
1.94
ug/l
—
6
9
89
557
1.66
4.58
10.0
8.3
91.67
93.24
%
0.77
89
552
7
5
14.09
4.58
1.1
1.2
—
—
—
0
0
473
4062
1.32
4.39
5.1
4.1
12.05
0.00
estimate
0.50
102
856
32
145
2.25
4.31
2.2
1.9
217.63
15.49
u/ml
0.48
32
113
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
38
3.99
4.31
1.2
1.2
—
—
—
0
0
626
6865
0.75
4.24
4.8
5.4
1.26
1.43
mmol/l
18.18
558
6250
20
73
2.78
4.20
1.3
1.1
—
—
—
0
0
48
257
1.91
4.19
2.7
3.6
0.81
0.83
nmol/l
0.12
30
213
464
3992
1.31
4.18
5.1
4.1
0.00
0.00
estimate
-0.00
100
824
473
4086
1.31
4.12
5.2
4.1
0.01
0.01
estimate
0.10
89
809
19
69
2.79
4.03
1.1
1.1
—
—
—
0
0
12
27
4.49
3.94
1.1
1.1
—
—
—
0
0
58
337
1.77
3.93
3.5
3.0
4.18
4.41
pmol/l
0.91
53
295
87
564
1.60
3.92
10.0
8.1
1.62
1.33
%
1.66
87
558
11
23
4.82
3.88
1.2
1.1
—
—
—
0
0
11
23
4.82
3.88
1.2
1.1
—
—
—
0
0
41
214
1.96
3.87
2.5
2.3
105.10
130.48
g/l
5.22
31
174
7
8
8.80
3.77
1.1
1.1
97.00
105.50
%
—
7
8
7
8
8.80
3.77
1.0
1.5
—
—
—
0
0
18
67
2.72
3.67
1.6
1.3
23604.38
197931.76
e6/l
0.97
13
46
39
205
1.94
3.63
1.3
1.1
—
—
—
0
0
14
40
3.54
3.61
1.1
1.0
—
—
—
0
0
638
6928
0.77
3.61
5.1
5.5
3.96
4.39
mmol/l
17.97
572
6354
328
2734
1.30
3.60
2.9
2.3
337.37
281.13
u/l
0.09
306
2573
39
208
1.91
3.49
1.3
1.1
—
—
—
0
0
24
106
2.30
3.47
2.7
1.2
15.77
23.58
iu/l
0.91
17
92
12
32
3.78
3.39
2.8
1.2
—
—
—
0
0
34
176
1.97
3.32
2.3
2.6
32.48
37.00
umol/l
0.50
27
159
6
7
8.62
3.26
1.0
1.0
—
—
—
0
0
7
11
6.40
3.19
1.1
1.1
—
—
—
0
0
131
967
1.41
3.17
3.9
5.5
30.05
33.08
%
2.30
92
614
57
354
1.65
3.09
2.3
2.1
288.37
537.48
ug/l
0.86
51
330
5
5
10.04
2.98
1.0
1.0
—
—
—
0
0
111
808
1.42
2.92
6.2
3.3
—
—
—
0
0
12
38
3.18
2.85
1.1
1.0
—
—
—
0
0
29
151
1.95
2.82
1.2
1.4
—
—
—
0
0
21
98
2.17
2.72
1.5
1.4
47.56
66.23
%
1.16
16
61
46
281
1.67
2.69
1.3
1.3
—
—
—
0
0
9
24
3.77
2.67
1.1
1.2
—
—
—
0
0
34
193
1.79
2.57
2.2
1.7
—
—
—
0
0
90
647
1.43
2.55
1.4
1.7
1.70
1.57
%
0.45
69
552
8
21
3.83
2.46
1.0
1.1
—
—
—
0
0
146
1144
1.33
2.45
1.3
1.3
14.38
11.09
u/ml
0.17
46
419
527
5741
0.82
2.43
87.5
21.9
329.39
331.74
g/l
5.23
520
5705
390
3445
1.22
2.39
2.8
2.4
77.42
78.47
nmol/l
0.32
356
2991
10
33
3.05
2.36
1.0
1.1
—
—
—
0
0
24
127
1.91
2.27
1.6
2.0
3.67
4.66
mmol/24h
0.85
19
110
146
1818
0.77
2.27
3.2
3.0
0.82
0.77
ug/l
0.28
95
1256
8
23
3.50
2.27
1.0
1.2
—
—
—
0
0
114
873
1.35
2.24
2.8
2.6
7.98
6.86
ug/l
0.11
90
755
270
2312
1.23
2.20
5.2
4.1
0.00
0.00
estimate
-0.00
87
749
9
30
3.02
2.15
1.0
1.1
1591.78
1752.57
miu/ml
—
9
30
661
6990
0.83
1.97
6.6
5.7
6.06
6.12
mmol/l
0.51
593
6288
17
84
2.04
1.96
1.1
1.1
—
1.30
—
0
11
261
2994
0.82
1.93
3.1
3.4
6.68
7.32
mmol/l
1.82
230
2526
94
721
1.34
1.86
3.1
2.2
0.55
0.40
e6/l
0.23
94
681
18
93
1.95
1.86
1.7
1.3
—
—
—
0
0
263
2995
0.83
1.77
4.0
4.1
9.00
8.40
mg/mmol
0.10
178
1904
23
380
0.60
1.69
1.8
2.0
—
—
—
0
0
100
787
1.30
1.67
2.2
2.3
143.40
168.35
ug/g
0.43
82
620
7
25
2.81
1.65
1.0
1.1
114.57
165.06
iu/ml
—
7
25
7
25
2.81
1.65
12.7
2.7
4.94
5.12
kpa
—
7
25
7
25
2.81
1.65
12.7
2.7
12.31
9.57
kpa
—
7
25
623
6582
0.85
1.63
5.3
4.6
1.36
1.26
mmol/l
2.43
559
5921
8
32
2.51
1.60
1.0
1.3
—
—
—
0
0
147
1224
1.24
1.56
1.3
1.3
22.78
32.45
iu/ml
1.62
45
374
68
513
1.35
1.53
5.2
3.5
46.12
46.46
%
0.04
68
502
0
43
0.00
1.52
0.0
1.6
—
60.38
—
0
34
21
343
0.60
1.50
1.8
1.9
—
—
—
0
0
104
837
1.27
1.48
4.2
2.9
4.40
4.38
kpa
0.03
99
805
9
38
2.38
1.46
1.0
1.2
—
—
—
0
0
102
825
1.26
1.40
1.4
1.4
—
—
—
0
0
30
199
1.52
1.36
1.3
1.4
254.44
306.54
ug/g
0.70
18
122
232
2614
0.85
1.34
4.2
4.1
22.08
24.53
%
1.49
107
1294
0
39
0.00
1.34
0.0
1.6
—
1.19
—
0
26
0
39
0.00
1.34
0.0
1.6
—
1.03
—
0
26
0
39
0.00
1.34
0.0
1.6
—
1.01
—
0
26
13
68
1.92
1.33
1.0
1.1
—
—
—
0
0
736
7078
1.17
1.26
69.4
16.5
31.85
26.86
mg/l
3.60
707
5871
13
70
1.87
1.24
1.0
1.1
—
—
—
0
0
6
127
0.47
1.17
1.3
1.2
0.79
0.90
g/l
—
6
127
645
6728
0.88
1.15
51.7
16.1
74.68
73.18
ml/min/173m2
1.01
609
6233
740
7645
0.86
1.14
97.9
24.8
104.28
134.06
g/l
213.63
725
7520
740
7643
0.87
1.12
97.8
25.0
31.78
39.93
%
174.76
724
7517
740
7643
0.87
1.12
97.0
24.6
3.47
4.43
e12/l
155.38
717
7404
740
7642
0.87
1.12
97.3
24.6
167.18
238.35
e9/l
39.82
718
7432
740
7640
0.87
1.10
97.0
24.5
95.25
91.69
fl
34.45
727
7516
5
21
2.39
1.09
1.2
1.2
—
—
—
0
0
8
41
1.96
1.09
3.0
3.8
—
—
—
0
0
12
68
1.77
1.00
1.2
1.2
—
—
—
0
0
9
48
1.88
1.00
1.6
1.1
—
—
—
0
0
9
49
1.84
0.98
1.6
1.1
—
—
—
0
0
5
23
2.18
0.98
2.2
1.2
—
—
—
0
0
184
1639
1.15
0.95
3.2
2.2
2.43
2.45
mmol/l
1.30
170
1440
6
120
0.50
0.93
1.3
1.2
1.60
1.52
g/l
—
6
120
11
63
1.75
0.90
1.0
1.1
—
—
—
0
0
643
6667
0.89
0.90
5.7
5.1
2.10
2.02
mu/l
0.77
590
6041
5
104
0.48
0.89
1.6
1.3
0.48
18.39
nmol/l
—
5
96
25
178
1.42
0.87
4.3
3.5
40.78
25.15
mg/l
2.01
20
133
736
7567
0.89
0.87
72.5
22.1
84.83
84.19
umol/l
0.19
719
7446
31
233
1.34
0.80
1.5
1.6
24.82
20.34
u/ml
—
6
44
0
24
0.00
0.79
0.0
1.3
—
11.25
—
0
24
117
1024
1.16
0.79
13.0
7.6
—
—
—
0
0
0
27
0.00
0.77
0.0
1.3
—
9.22
—
0
27
5
25
2.01
0.72
1.0
1.1
—
—
—
0
0
7
39
1.80
0.72
2.1
2.6
—
—
—
0
0
723
7413
0.90
0.70
41.9
10.6
25.67
24.75
u/l
0.85
700
7103
224
2068
1.11
0.67
4.2
3.6
0.00
0.00
estimate
0.80
76
645
10
155
0.64
0.66
2.0
2.0
163.20
217.69
pmol/l
—
10
147
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
79
690
1.16
0.58
3.1
3.7
64.39
93.86
ng/l
5.63
70
584
6
36
1.67
0.56
1.3
2.3
54.43
51.90
umol/l
—
6
30
23
293
0.78
0.52
1.1
1.0
—
—
—
0
0
43
360
1.20
0.52
1.1
1.2
52.70
111.04
u/ml
—
10
142
7
48
1.46
0.47
2.0
2.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
179
1906
0.93
0.41
5.6
4.3
1.02
1.02
kg/l
0.23
140
1260
8
111
0.72
0.37
1.8
1.5
—
—
—
0
0
32
273
1.18
0.35
1.5
1.6
0.08
0.36
mg/l
8.00
14
117
9
125
0.72
0.35
2.2
1.5
—
—
—
0
0
554
5654
0.95
0.30
84.8
20.0
16.76
13.74
%
83.44
549
5554
5
73
0.68
0.26
1.0
1.2
—
—
—
0
0
14
170
0.82
0.25
1.9
2.3
—
—
—
0
0
735
7432
0.95
0.24
66.8
21.1
4.01
4.01
mmol/l
0.01
722
7261
5
41
1.22
0.22
1.2
1.5
80.00
88.00
umol/l
—
5
41
0
11
0.00
0.21
0.0
2.6
—
0.45
—
0
11
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
8
101
0.79
0.21
1.1
1.1
—
111.07
—
0
14
12
145
0.83
0.21
1.7
2.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
51
1.18
0.19
1.2
1.7
65.83
104.70
ng/l
—
6
51
311
3036
1.04
0.19
5.1
4.1
0.00
0.01
estimate
1.22
88
684
736
7426
0.96
0.18
60.6
21.0
138.69
139.74
mmol/l
21.76
720
7266
14
119
1.18
0.17
3.3
2.3
1.20
1.18
mmol/l
0.44
14
119
16
138
1.16
0.17
1.3
2.0
2.67
38.19
iu/l
—
5
68
19
214
0.89
0.16
2.2
2.3
116.40
72.31
ug/min
—
10
130
12
102
1.18
0.15
1.4
1.6
—
—
—
0
0
14
123
1.14
0.12
3.3
2.2
3.96
4.07
mmol/l
0.42
14
123
14
123
1.14
0.12
3.3
2.2
106.50
105.33
mmol/l
0.57
14
123
66
636
1.04
0.09
1.6
1.4
—
—
—
0
0
557
5529
1.02
0.08
4.5
4.0
14.96
15.08
pmol/l
0.45
505
4960
57
591
0.96
0.07
4.8
2.6
55.69
61.31
ml/min/173m2
0.73
36
265
317
3196
0.99
0.05
5.1
4.4
1.93
2.16
ug/l
0.93
281
2845
13
122
1.07
0.02
1.6
1.7
313.62
282.57
mu/l
0.37
13
114
22
222
0.99
0.00
6.0
2.9
6.98
7.57
mmol/l
0.59
22
215
151
1512
1.00
0.00
1.3
1.3
2.50
1.42
u/ml
0.34
31
401
60
599
1.00
0.00
1.4
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
5.96
—
0
8
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
62
0.97
-0.00
1.2
1.2
100.00
102.45
pmol/l
—
6
62
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_AML_MDS – Acute myeloid leukaemia and myelodysplastic syndromes
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).